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Abstract
Background: Cytokines and alcohol share a common modulation of inflammation and hormones as well
as being implicated in multiple diseases, but the mechanisms are poorly understood. The purpose of this
study was to investigate the interaction of liver, serum and brain cytokines as well as whether ethanol
would potentiate endotoxin (Lipopolysaccharide, LPS) responses once ethanol had cleared.
Methods: Male C57BL/6J mice were treated intragastrically with water (control) or ethanol (5 g/kg, i.g.,
25% ethanol, w/v), with volumes matched, for 1 day or daily for 10 days. Mice were then injected
intraperitoneally with saline (control) or LPS (3 mg/kg, i.p.) in saline 24 hrs after the last dose of ethanol.
Gene expression and protein synthesis of proinflammatory cytokines and anti-inflammatory cytokine,
oxidative enzymes, microglial activation and inhibition of neurogenesis were examined using real-time
PCR, ELISA, and immunohistochemistry.
Results: LPS increased proinflammatory cytokines (TNFα, MCP-1, IL-1β) several fold in liver, brain and
serum at 1 hr. Ethanol is known to increase liver cytokines and alter the risk of multiple chronic diseases.
Ten daily doses of ethanol increased brain and liver TNFα, and pretreatment with ethanol potentiated LPS-
induced increases in TNFα, MCP-1, IL-1β in liver, serum and brain. Proinflammatory cytokine levels in liver
and serum returned to basal levels within a day, whereas brain proinflammatory cytokines remained
elevated for long periods. IL-10, an anti-inflammatory cytokine, is reduced in brain by ethanol and LPS,
while brain proinflammatory cytokines remain increased, whereas liver IL-10 is increased when
proinflammatory cytokines have returned to control levels. Activation of brain microglia indicated by
morphological changes, reduced neurogenesis and increased brain expression of COX-2 and gp91phox
NADPH oxidase subunit mRNA were found in the 10 daily doses of ethanol-pretreated LPS group.
Conclusion: Acute increases in serum cytokines induce long lasting increases in brain proinflammatory
cytokines. Ten daily doses of ethanol exposure results in persistent alterations of cytokines and
significantly increases the magnitude and duration of central and peripheral proinflammatory cytokines and
microglial activation. Ethanol induced differential anti-inflammatory cytokine IL-10 responses in liver and
brain could cause long lasting disruption of cytokine cascades that could contribute to protection or
increased risk of multiple chronic diseases.
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Cytokines have been increasingly recognized as factors
much like hormones regulating homeostatic responses
among multiple tissues. One role of cytokines is to mod-
ulate inflammatory responses by shifting from Th1, proin-
flammatory cascades, to Th2, anti-inflammatory healing
cascades [1]. Tumor necrosis factor alpha (TNFα), a key
proinflammatory cytokine, induces the secretion of other
cytokines and enzymes in various cells and tissues.
Inflammation and proinflammatory cytokine cascades
have been implicated in a variety of diseases affecting
heart, lung, and liver, as well as the central nervous sys-
tem. The gram-negative bacteria endotoxin, lipopolysac-
charide (LPS), activates proinflammatory cytokine
cascades through plasma membrane proteins, e.g. the toll-
like receptor 4 (TLR4) and CD14, which leads to the pro-
duction of TNFα and other proinflammatory cytokines. In
addition, TNFα and other cytokines regulate the release of
adrenal and other hormones, and also affect central nerv-
ous system function. Although LPS has been extensively
used to study proinflammatory effects on peripheral tis-
sue/organs, the influence of systemic inflammation on
brain cytokines is not clear. Recently, we found that sys-
temic LPS administration induced TNFα production in
liver, serum and brain within one hour [2]. These studies
indicated that TNFα from serum rapidly activates a proin-
flammatory cascade in brain. In the present study we
extend these findings to varied doses of LPS that range
from low to maximal cytokine responses [2]. Further we
measured the proinflammatory cytokines MCP-1 and IL-
1β, since MCP-1 has been found to be increased in the
brains of alcoholic humans [3] and IL-1β is a key proin-
flammatory cytokine associated with neurodegeneration
[4]. In addition, we measured IL-10, a Th2 prototype also
known as human cytokine synthesis inhibitory factor,
which down-regulates the expression of proinflammatory
Th1 cytokines, MHC class II Ags, and costimulatory mol-
ecules on macrophages. In the present study we deter-
mined the effects of ethanol and LPS on these multiple
cytokines in order to better understand the relationship
among liver, serum and brain cytokine synthesis.
To gain insight into the impact of ethanol-LPS on brain
we measured the proliferation and differentiation of neu-
roprogenetors in hippocampal dentate gyrus. These pro-
genitors have been implicated in regulating mood and
certain cognitive abilities. Hippocampal neuroprogene-
tors are inhibited by both ethanol [5] and LPS [6].
Changes in brain progenitors could contribute to the
degeneration associated with prolonged neuroinflamma-
tion and alcohol abuse.
Alcohol (ethanol) is a common dietary constituent that
impacts health. Although moderate alcohol consumption
has a protective effect on heart disease and appears to also
have other health benefits, heavy drinking increases mor-
tality by escalating the risk of multi-system diseases in
peripheral organs as well as psychiatric and neurological
disorders in the central nervous system [7]. The mecha-
nisms of alcohol induced benefits or increased risk of
morbidity are not well understood. Generally, alcohol
abuse is associated with disruption of immune defenses
against infections, increased incidence of bacterial pneu-
monias, higher rates of chronic hepatitis C infection, and
increased susceptibility to HIV infection [7-10]. In
humans, chronic alcohol consumption is associated with
increases in serum proinflammatory cytokines including
TNFα, IL-1β, and other cytokines [11,12]. Monocytes iso-
lated from the blood of alcoholics produce greater
amounts of TNFα spontaneously and in response to endo-
toxin challenge [13]. Chronic alcohol consuming preg-
nant women and their fetus show elevated levels of blood
cytokines including TNFα, IL-1β and IL-6 as determined
by using cord blood [14]. Interestingly, studies have sug-
gested that TNFα through regulation of leptin formation
contributes to craving for alcohol [15]. Ethanol induced
alterations in cytokines might contribute to both the
health benefits and increased risk for poor health associ-
ated with alcohol consumption. Although acute alcohol
can directly inhibit endotoxin cytokine responses in vitro
[1], the effects of chronic ethanol exposure have not been
systematically studied. To avoid the acute direct effect of
ethanol, cytokines were measured 24 hours after ethanol
treatment to ensure the absence of ethanol before measur-
ing cytokines. We report here that ethanol exposure
induces liver, serum and brain cytokines and markedly
increases LPS-induced cytokine responses. Liver and sys-
temic cytokine responses decline within one week, associ-
ated with an increase in IL-10, an anti-inflammatory
cytokine, whereas in brain a long lasting increase in proin-
flammatory cytokines (TNFα, IL-1β and MCP-1) occurs
while IL-10 is reduced. These findings on systemic proin-
flammatory cytokines, anti-inflammatory cytokines and
long lasting brain induction of proinflammatory




Eight-week old male (20–22 g) C57BL/6J mice were pur-
chased from Jackson Laboratories (Bar Harbor, Maine).
Animals were randomly assigned to different groups and
treated according to each group protocol. All protocols in
this study were approved by the Institutional Animal Care
and Use Committee and were in accordance with the
National Institute of Health regulations for the care and
use of animals in research.Page 2 of 17
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Lipopolysaccharide (LPS, strain O111:B4) was purchased
from Calbiochem (San Diego, CA). Rabbit anti-Iba1 anti-
body was purchased from Wako Pure Chemical Indus-
tries, Ltd. (1–2Doshomachi 3-Chome Chuo-ku Osaka
540–8605, Japan). Anti-mouse PCNA was purchased
from DAKO Corporation (Carpinteria, CA) and anti-goat
doublecortin was purchased from Santa Cruz Biotechnol-
ogy (Santa Cruz, CA). TNFα, IL-1β, MCP-1 and IL-10
ELISA kits were purchased from R & D Systems Inc. (Min-
neapolis, MN). All other reagents came from Sigma
Chemical Co. (St. Louis, MO).
Animal treatments
Male C57BL/6J mice were treated intragastrically with
water (control) or ethanol (5 g/kg, i.g., 25% ethanol w/v),
with volumes matched, for one day or daily for 10 days.
Blood alcohol level at 1 hr after a single dose of ethanol (5
g/kg, i.g.) was 310 mg/dl ± 8.9 (w/v, n = 12). Levels of 10
daily doses of ethanol were measured at 1 hr after the first
dose of ethanol (5 g/kg, i.g.) and 1 hr after the ninth dose
of ethanol, which are 304 mg/dl ± 12 (w/v, n = 12) and
316 mg/dl, ± 11 (w/v, n = 12), respectively. These blood
ethanol levels are high and considered to model binge
drinking [16]. Mice were then injected intraperitoneally
with saline (control) or LPS (3 mg/kg, i.p.) in saline 24 hrs
after the last dose of ethanol. Mice were sacrificed at indi-
cated time points (1 hour and 1 week following LPS injec-
tion), and their livers, brains and sera were used for either
morphological or biochemical (mRNA and protein) anal-
yses. Observation of potential toxicity of these treatments
revealed that ethanol treated mice did not show signifi-
cant signs of toxicity. Grooming declined initially.
Although 10 day ethanol treatment groups showed a
trend to lower body weights, body weight was not signifi-
cantly different from controls. Procedures using labora-
tory animals were in accordance with the National
Institutes of Health guidelines for the use of live animals
and approved by IUCAC boards.
Immunohistochemistry
Brains were fixed and processed for immunostaining as
described previously [17]. Microglia were stained with
rabbit anti-Iba1 antibody. Immature and newborn neu-
rons were stained with either anti-mouse proliferating cell
nuclear antigen (PCNA) or anti-goat doublecortin anti-
bodies. Immunostaining was visualized by using nickel-
enhanced 3,3'-diaminobenzidinne (DAB) as a chrom-
agen.
Real-time PCR analysis
Total RNA was extracted from the mouse brain and liver
samples treated with ethanol, LPS, ETOH-LPS or saline at
the indicated time points and reverse transcribed as
described previously [17]. The primer sequences used in
this study were as follows: TNFα, 5'-GAC CCT CAC ACT
CAG ATC ATC TTC T-3' (forward) and 5'-CCT CCA CTT
GGT GGT TTG CT-3' (reverse); IL-1β, 5'-CTG GTG TGT
GAC GTT CCC ATT A-3' (forward) and 5'-CCG ACA GCA
CGA GGC TTT-3' (reverse); MCP-1, 5'-ACT GAA GCC
AGC TCT CTC TTC CTC-3' (forward) and 5'-ACT GAA
GCC AGC TCT CTC TTC CTC-3' (reverse); COX-2, 5'-GCT
GGC CTG GTA CTC AGT AGG TT-3' (forward) and 5'-
CGA GGC CAC TGA TAC CTA TTG C-
3'(reverse);gp91phox, 5'-CAG GAG TTC CAA GAT GCC TG-
3' (forward) and 5'-GAT TGG CCT GAG ATT CAT CC-3'
(reverse); p67phox, 5'-CAG CCA GCT TCG GAA CAT G-3'
(forward) and 5'-GAC AGT ACC AGG ATT ACA TC-3'
(reverse); DBI, 5'-GCC AGT ATG TCT CAG GCT GA-3'
(forward) and 5'-AGG CAT TAT GTC CTC ACA GG-3'
(reverse); IL-10, 5'-GGT TGC CAA GCC TTA TCG GA-3'
(forward) and 5'-ACC TGC TCC ACT GCC TTG CT-3'
(reverse); β-actin, 5'-GTA TGA CTC CAC TCA CGG CAA A-
3' (forward) and 5'-GGT CTC GCT CCT GGA AGA TG-3'
(reverse). The SYBR green PCR master mix (Applied Bio-
systems, Foster City, CA) was used for real-time PCR anal-
ysis. The relative differences in expression between groups
were expressed using cycle time (Ct) values normalized
with β-actin, and relative differences between control and
treatment groups were calculated and expressed as relative
increases setting control as 100%.
Beta-actin is an abundant mRNA commonly used to nor-
malize less abundant mRNA [18]. To ensure that treat-
ments did not alter beta-actin levels the Ctvalues of the
beta-actin were compared between groups. For example,
for Table 1, a comparison of control to the 10 daily doses
of EtOH group the average CT value was 18.75 ± 0.14 and
18.87 ± 0.06, p = 0.48, n = 5, respectively. No significant
difference was found in any treatment groups for beta-
actin. Therefore, we used beta-actin to normalize mRNA
levels.
TNFα, IL-1β, MCP-1 and IL-10 assays
Frozen livers and brains were homogenized in 100 mg tis-
sue/ml cold lysis buffer (20 mM Tris, 0.25 M sucrose, 2
mM EDTA, 10 mM EGTA, 1% Triton ×-100) and 1 tablet
of Complete Mini protease inhibitor cocktail tablets/10
ml (Roche Diagnostics, Indianapolis, IN). Homogenates
were centrifuged at 100,000 × g for 40 min, supernatant
was collected, and protein levels determined using the
BCA protein assay reagent kit (PIERCE, Milwaukee, WI).
The levels of TNFα, MCP-1, IL-1β and IL-10 in livers, sera
and brains were measured with TNFα, mouse JE/MCP-1,
IL-1β and IL-10 commercial enzyme-linked immunosorb-
ent assay (ELISA) kits from R&D Systems (Minneapolis,
MN), as described previously [19].Page 3 of 17
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The data are expressed as mean ± SEM and statistical sig-
nificance was assessed with an ANOVA followed by Bon-
ferroni's t-test. A value of P < 0.05 was considered
statistically significant.
Results
Liver, serum and brain pro-inflammatory cytokines
To investigate liver, serum and brain cytokines, endotoxin
(lipopolysaccharide, LPS, 3 mg/kg, i.p.) was administered
and cytokine levels were determined. LPS induced large
increases in TNFα, MCP-1, and IL-1β mRNA and protein
levels in liver, serum and brain within 1 hour (Fig. 1, 2,
Table 2). Changes in mRNA are generally very large and
are described as fold increases over control, whereas pro-
tein changes tend to be smaller and are presented as per-
cent changes with absolute values in figures and tables.
TNFα mRNA was increased 137 fold in liver at 1 hour cor-
responding to about a 31 fold increase in TNFα protein in
liver and 100 fold increase in serum TNFα protein. MCP-
1 mRNA was increased 135 fold in liver corresponding to
a 54 fold increase in MCP-1 protein in liver and 57 fold
increase in serum MCP-1 protein. IL-1β mRNA increased
23 fold in liver corresponding to a 10 fold increase in IL-
1β protein in liver and 27 fold increase in serum IL-1β
protein. Although the brain also showed marked increases
in proinflammatory mRNA and protein the ratios were
somewhat different. LPS induced brain TNFα mRNA 47
fold, MCP-1 mRNA 3 fold and IL-1β mRNA 16 fold corre-
sponding to a 2–6 fold increase in protein levels at 1 hour
for these proinflammatory cytokines. Although LPS
induced increases in TNFα levels in serum and liver
peaked at about 1 hour [2], there may be a different time
course for other cytokines. Thus, LPS rapidly induces
TNFα, MCP-1, and IL-1β proinflammatory cytokines in
liver, serum and brain.
To investigate the effects of one dose of ethanol exposure
on TNFα, MCP-1 and IL-1β in liver, serum, and brain,
mice were pretreated with ethanol (5 g/kg, i.g.), a binge
drinking dose, and samples were taken 25 hours later to
ensure the absence of ethanol. This single dose of ethanol
alone did not elevate liver proinflammatory cytokines,
whereas brain mRNA for TNFα, MCP-1 and COX-2 were
increased (Table 2). LPS treatment 24 hours after one dose
of ethanol showed a potentiated proinflammatory
cytokine response in brain, but not in liver. In brain, the
TNFα mRNA response was increased 47 fold by LPS and
was potentiated to 196 fold in ethanol-LPS animals (Table
2). Similarly IL-1β mRNA in brain increased 16 fold after
LPS and was potentiated to 47 fold by one ethanol pre-
treatment. Protein levels of TNFα, MCP-1, and IL-1β
proinflammatory cytokines were increased in all tissues
measured. In brain and serum LPS induced IL-1β protein
levels were approximately doubled by a single ethanol
pretreatment (Fig. 2). One dose of ethanol pretreatment
also increased LPS-induced gene expression of gp91phox,
a subunit of NADPH oxidase, in the brain. Immunohisto-
chemistry for microglia using Iba1 immunostaining in
brains of a single ethanol dose and/or LPS treated mice
did not show marked morphological indications of acti-
vation 1 hr after LPS (images not shown). Interestingly,
the mRNA level of IL-10, the regulatory anti-inflamma-
tory cytokine, was increased many fold by LPS in liver and
Table 1: Ten daily doses of ethanol and LPS induced changes in gene expression in brain and liver
Gene Control ETOH LPS ETOH + LPS
Brain
TNFα 100 ± 19 362 ± 73** 9147 ± 3080* 9229 ± 1464*
MCP-1 100 ± 5 130 ± 7** 618 ± 156** 559 ± 186*
IL-1β 100 ± 9 133 ± 20 4172 ± 1115** 3962 ± 651*
COX-2 100 ± 10 82 ± 8 459 ± 43** 487 ± 72**
gp91phox 100 ± 11 194 ± 19** 155 ± 11** 239 ± 31**#
p67phox 100 ± 7 144 ± 11 106 ± 9 138 ± 29*
IL-10 100 ± 29 254 ± 72 5776 ± 1633* 7006 ± 2840
Liver
TNFα 100 ± 10 41 ± 7** 8560 ± 1284** 21238 ± 4810**##
MCP-1 100 ± 7 53 ± 3** 27787 ± 1580** 29249 ± 2338**
IL-1β 100 ± 21 27 ± 3** 6477 ± 691** 7197 ± 1647**
COX-2 100 ± 9 81 ± 24 12335 ± 1128** 6317 ± 707**
gp91phox 100 ± 7 119 ± 14 187 ± 13** 261 ± 22**#
p67phox 100 ± 9 108 ± 13 1 04 ± 17 129 ± 31
IL-10 100 ± 7 64 ± 10* 11428 ± 1543** 5625 ± 922**
Ten daily doses of ethanol and LPS induced changes in gene expression in brain and liver. Male C57BL/6J mice were treated intragastrically with 
ethanol (5 g/kg, i.g.) daily for 10 days and injected intraperitoneally (i.p.) with LPS (3 mg/kg) 24 hrs after ethanol treatment. Brain and liver samples 
were collected 1 hr post LPS treatment. Gene expression of proinflammatory and anti-inflammatory factors was measured by real-time PCR. The 
results are the means ± SEM (n = 6 per group). * P < 0.05, ** P < 0.01, compared with the saline controls. # P < 0.05, ## P < 0.01, compared with 
LPS-treated group.Page 4 of 17
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Effects of a single dose of ethanol exposure on LPS-induced liver, serum and brain TNFα productionFigure 1
Effects of a single dose of ethanol exposure on LPS-induced liver, serum and brain TNFα production. Male C57BL/6J mice were 
treated intragastrically with ethanol (5 g/kg, i.g.) for one day. Mice were injected intraperitoneally (i.p.) with LPS (3 mg/kg) 24 
hrs after ethanol treatment. Liver, serum and brain samples were collected at 1 hr post LPS treatment. Analysis of TNFα and 
MCP-1 protein was conducted by ELISA. (A) LPS and ETOH-LPS rapidly increased liver, serum and brain TNFα protein. (B) 
MCP-1 protein in liver, serum and brain was increased after LPS treatment alone or combined LPS and ethanol treatments. 
The results are the means ± SEM (n = 6 per group). * P < 0.05, ** P < 0.01, compared with the saline controls.
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A single dose of ethanol treatment enhanced LPS-induced IL-1β protein in brain and serum, but not in liverFigure 2
A single dose of ethanol treatment enhanced LPS-induced IL-1β protein in brain and serum, but not in liver. Male C57BL/6J 
mice were treated intragastrically with ethanol (5 g/kg, i.g.) for one day. Mice were injected intraperitoneally (i.p.) with LPS (3 
mg/kg) 24 hrs after ethanol treatment. Liver, serum and brain samples were collected at 1 hr after LPS injection. Liver, serum 
and brain IL-1β protein was measured by ELISA. (A) A single ethanol dose increased LPS-induced brain IL-1β production. (B) A 
single dose of ethanol increased LPS-induced IL-1β protein in serum. (C) A single dose of ethanol did not show potentiation to 
LPS-stimulated increase in IL-1β protein in liver. The results are the means ± SEM (n = 6 per group). * P < 0.05, ** P < 0.01, 
compared with the saline controls.# P < 0.05, ## P < 0.01, compared with LPS-treated group.
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increased brain IL-10 mRNA response to LPS from 16 to
50 fold, whereas LPS in liver showed 40–50 fold IL-10
mRNA increases due to LPS for IL-10 regardless of ethanol
pretreatment. These studies indicate that within 1 hour
LPS induces cytokines in liver, serum and brain. A single
dose of ethanol pretreatment potentiates LPS-induced
brain cytokine mRNA as well as IL-1β protein in serum
and brain.
Ten daily doses of ethanol induces proinflammatory 
cytokines and increases cytokine responses to systemic LPS 
administration
Chronic high alcohol ingestion is common among
20–30% of adults [20]. We administered a heavy drinking
dose of ethanol (5 g/kg) daily for 10 days to determine if
10 daily doses of ethanol ingestion with or without LPS
would alter cytokines. Interestingly, in 10 daily doses of
ethanol treated mice, 25 hrs after the last dose of ethanol,
there were significant increases in liver and brain TNFα
and MCP-1 protein (Fig. 3). IL-1β did not show an effect
with ethanol alone on protein levels in either tissue (Fig.
4). Ten daily doses of ethanol pretreatment significantly
enhanced LPS induced TNFα, MCP-1 and IL-1β mRNA
and protein. Large increases in mRNA were found for
TNFα, MCP-1 and IL-1β in LPS treated animals, with 10
daily doses of ethanol pretreatment potentiating TNFα
mRNA levels in liver one hour after LPS treatment from 87
to 216 fold (Table 1). Ten daily doses of ethanol also
increased LPS-induced TNFβ protein in liver (178%),
serum (172%), and brain (132%), IL-1βprotein in liver
(156%), serum (271%), and brain (210%), and MCP-1
protein in liver (155%), serum (147%), and brain (209%)
compared to values for LPS treatment alone. These studies
indicate that 10 daily doses of ethanol alone can induce
proinflammatory TNFβ and MCP-1 protein in brain. Fur-
ther, 10 daily doses of ethanol pretreatment increases LPS
stimulated levels of proinflammatory cytokines in liver,
serum and brain.
A number of reports indicate that microglia, the resident
innate immune cells in the brain, can become activated in
response to diverse stimuli to produce proinflammatory
factors such as superoxide, TNFα, and IL-1β [6,21,22].
Microglia, identified by Iba1 immunoreactivity (Iba1+IR),
were evaluated morphologically for activation. One hour
after LPS (3 mg/kg i.p.) or 25 hrs after 10 doses of ethanol
(5 g/kg, i.g.) microglia show a resting morphological
shape (Fig. 5). However, in the 10 daily doses of ethanol
pretreated group, LPS at 1 hour increased Iba1 staining in
multiple brain regions, e.g. cortex, hippocampus and sub-
stantia nigra. Iba1+IR cells in the 10 daily doses of etha-
nol-LPS group showed increased cell size and irregular
shape consistent with morphological activation of micro-
glia. These studies indicate that 10 daily doses of ethanol
increased induction of proinflammatory cytokines and
morphological signs of microglial activation by LPS.
Neuroinflammation is associated with most neurodegen-
erative diseases. Neurogenesis is a growth and regenera-
tive component of the brain which when inhibited
represents a form of degeneration. Neurogenesis is inhib-
ited by chronic LPS induced neuroinflammation [6].
Using PCNA, a marker for neuroprogenitor proliferation,
Table 2: A single dose of ethanol and LPS induced changes in gene expression in brain and liver
Gene Control ETOH LPS ETOH + LPS
Brain
TNFα 100 ± 13 413 ± 100* 4595 ± 1360* 19079 ± 6532*
MCP-1 100 ± 5 146 ± 12** 291 ± 65 1294 ± 215*
IL-1β 100 ± 15 91 ± 12 1536 ± 385* 4534 ± 810**#
COX-2 100 ± 6 154 ± 13** 386 ± 41** 474 ± 44**
gp91phox 100 ± 9 127 ± 9 138 ± 19 228 ± 44*#
p67phox 100 ± 10 131 ± 12 116 ± 10 98 ± 18
IL-10 100 ± 13 59 ± 20 1578 ± 825 4864 ± 873*
Liver
TNFα 100 ± 7 121 ± 30 13632 ± 2417** 13894 ± 984**
MCP-1 100 ± 9 86 ± 10 13279 ± 2004** 21332 ± 5143**
IL-1β 100 ± 15 20 ± 2** 2215 ± 211** 2232 ± 457**
COX-2 100 ± 27 136 ± 11 9663 ± 1056** 8296 ± 467**
gp91phox 100 ± 12 62 ± 5* 125 ± 12 131 ± 25
p67phox 100 ± 15 61 ± 4* 106 ± 18 81 ± 14
IL-10 100 ± 20 26 ± 4** 3615 ± 394** 4854 ± 979**
Ethanol and LPS induced changes in gene expression in brain and liver. Male C57BL/6J mice were treated intragastrically with ethanol (5 g/kg, i.g.) 
for one day. Mice were injected intraperitoneally (i.p.) with LPS (3 mg/kg) 24 hrs after ethanol treatment. Brain and liver samples were collected at 
1 hr post LPS treatment. Gene expression of proinflammatory and anti-inflammatory factors was measured by real-time PCR. The results are the 
means ± SEM (n = 6 per group). * P < 0.05, ** P < 0.01, compared with the saline controls. # P < 0.05 compared with LPS-treated group.Page 7 of 17
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Effects of 10 daily doses of ethanol exposure on LPS-induced liver, serum and brain TNFα and MCP-1 productionFigure 3
Effects of 10 daily doses of ethanol exposure on LPS-induced liver, serum and brain TNFα and MCP-1 production. Male 
C57BL/6J mice were treated intragastrically with ethanol (5 g/kg, i.g.) daily for 10 days and injected intraperitoneally (i.p.) with 
LPS (3 mg/kg) 24 hrs after ethanol treatment. Liver, serum and brain samples were collected 1 hr post LPS treatment. TNFα 
and MCP-1 protein was determined by ELISA. (A) In 10-day ethanol pre-treated group, LPS significantly increased liver, serum 
and brain TNFα protein compared with LPS alone group. (B) Exposure to 10 daily doses of ethanol resulted in a significant 
increase in MCP-1 protein in liver, serum and brain. The results are the means ± SEM of two experiments performed with 6 
mice each group. * P < 0.05, ** P < 0.01, compared with the saline controls. # P < 0.05, ## P < 0.01, compared with LPS-treated 
group.
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Effects of 10 daily doses of ethanol exposure on LPS-induced liver, serum and brain IL-1β productionFigure 4
Effects of 10 daily doses of ethanol exposure on LPS-induced liver, serum and brain IL-1β production. Male C57BL/6J mice 
were treated intragastrically with ethanol (5 g/kg, i.g.) for 10 days and injected intraperitoneally (i.p.) with LPS (3 mg/kg) 24 hrs 
after ethanol treatment. Liver, serum and brain samples were collected 1 hr after LPS injection. LPS significantly increased IL-1β 
protein in liver, serum and brain after 10 days of ethanol administration compared with LPS alone treatment. The results are 
the means ± SEM of two experiments performed with 6 mice each group. * P < 0.05, ** P < 0.01, compared with the saline 
control mice. # P < 0.05, ## P < 0.01, compared with LPS-treated mice.
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Immunocytochemical analysis of microgliaFigure 5
Immunocytochemical analysis of microglia. Male C57BL/6J mice were treated intragastrically with ethanol (5 g/kg, i.g.) for 10 
days and injected intraperitoneally (i.p.) with LPS (3 mg/kg, i.p.) 24 hrs after ethanol treatment. Mice were sacrificed 1 hr fol-
lowing saline or LPS injection. Brain sections were fixed and stained with Iba1 antibody. Ten daily doses of ethanol exposure 
potentiated LPS-induced microglial activation. In either LPS or ethanol treated groups, most of the microglia were in a resting 
morphological shape. However, in the ethanol pre-treated group, LPS increased Iba1 staining in some brain regions such as 
cortex, hippocampus and substantia nigra. Iba1-immunoreactive (IR) cells showed an increased cell size, irregular shape consist-
ent with morphological changes in activated microglia.
Journal of Neuroinflammation 2008, 5:10 http://www.jneuroinflammation.com/content/5/1/10and doublecortin (DCX), a marker for immature or newly
born neurons, we assessed neurogenesis in adult hippoc-
ampus. In this study, neurogenesis was not decreased 25
hrs after a single ethanol dose or 1 hour after LPS or etha-
nol-LPS treatments. Neurogenesis was significantly
decreased in 10 daily doses of ethanol-LPS treated ani-
mals (Fig. 6). Both proliferation of hippocampal neuro-
progenitors (PCNA) and new born neuron differentiation
(DCX) were decreased in 10 daily doses of ethanol-LPS
treated animals that also showed morphology of activated
microglia. These findings suggest that the combination of
ethanol and LPS insult neurogenesis greater than either
treatment alone.
Persistent long lasting increases in proinflammatory 
cytokines in brain, but not in liver and serum
To investigate the effects of 10 daily doses of ethanol (5 g/
kg, i.g.) on the duration of the response, LPS was given 24
hours after the last dose of ethanol, and cytokines were
measured 1 week after LPS. In addition, several doses of
LPS were used (0.03, 0.3 and 3 mg/kg) in order to better
detect the potentiation from 10 daily doses of ethanol
treatment. After 1 week, there were no significant differ-
ences in liver or serum protein levels of proinflammatory
cytokines (TNFα, IL-1β and MCP-1) in any groups com-
pared to the saline control group. Similarly liver mRNA
for TNFα, MCP-1 and IL-1β were at or below control lev-
els 1 week after LPS (Table 3). Interestingly, IL-10 mRNA
(Table 3) and protein (Fig. 7) were elevated in liver at this
delayed time point, i.e. 8 days after ethanol and/or 7 days
after LPS. These findings suggest that the proinflammatory
cytokine responses of liver and serum are transient, per-
haps due to a delayed increase in IL-10.
Although induction of proinflammatory cytokines in liver
and serum were transient, brain showed persistent eleva-
tion of proinflammatory genes by both LPS and ethanol.
Remarkably, in brain MCP-1 protein and mRNA were
increased (138%, p < 0.05 for protein; 1.38 fold, p < 0.01
for mRNA) 8 days after the last ethanol treatment (Fig. 8,
Table 3). Brain MCP-1 mRNA was increased 24 hrs after a
single dose of ethanol (Table 2) and both protein and
mRNA were increased after 10 daily doses of ethanol
(Table 1, Fig. 3) and remained increased 8 days after 10
daily doses of ethanol exposure (Table 3, Fig. 8) indicating
that this proinflammatory cytokine is exceptionally
responsive to ethanol. The proinflammatory enzyme that
makes reactive oxygen species, NADPH oxidase, showed
increased mRNA for subunits, gp91phox, and p67phox that
persist for 1 week after ethanol and/or LPS.
Also elevated in brain 1 week after ethanol and/or LPS was
diazepam binding inhibitor (DBI), a regulator of micro-
glial steroid metabolism induced by proinflammatory
stimuli (Table 3). Ten daily doses of ethanol pretreatment
increased both the potency and efficacy of LPS at inducing
both protein and mRNA levels of TNFα, MCP-1, and IL-1β
(Fig. 8, Table 3) and markers of neuroinflammation e.g.
mRNA for diazepam binding inhibitor (DBI), and
NADPH oxidase (Table 3). Although proinflammatory
cytokines and other markers of inflammation remained
elevated, markers of neurogenesis, e.g. PCNA and DCX,
had returned to control levels 1 week after LPS with or
without ethanol pretreatment (data not shown). Thus,
increases in brain proinflammatory cytokines and genes
persist, although liver and serum proinflammatory
cytokines return to control levels after 1 week.
The differential response of liver and serum as compared
to the brain could be related to differences between brain
and liver IL-10, an anti-inflammatory cytokine. Ten daily
doses of ethanol significantly reduced brain IL-10 produc-
tion and enhanced a decrease in LPS-induced brain IL-10
protein in a LPS dose-dependent manner (Fig. 7). Interest-
ingly, the liver was opposite to that of the brain, with both
ethanol and LPS causing a significant increase in liver IL-
10 protein. Ten daily doses of ethanol pretreatment
potentiated both the LPS induced decrease in IL-10 in
brain and the LPS-induced increase in IL-10 in liver (Fig.
7). Thus, in brain, 10 daily doses of ethanol induced a
long lasting increase in proinflammatory cytokines and
potentiated multiple brain LPS proinflammatory cytokine
responses while decreasing the anti-inflammatory
cytokine IL-10. In the liver and serum, ethanol induced
proinflammatory cytokines and increased multiple brain
LPS proinflammatory cytokine responses at 1 hr, the peak
of the TNFα response, whereas hepatic and systemic levels
of proinflammatory cytokines subsided after 1 week when
the anti-inflammatory cytokine IL-10 was increased.
Discussion
To our knowledge, this is the first report to show the strik-
ing concordance of proinflammatory cytokine (TNFα,
MCP-1, and IL-1β) responses in liver, serum and brain to
LPS with or without ethanol pretreatment. The fascinating
discovery of the correlation of responses in liver, serum
and brain at 1 hour after LPS and/or ethanol, are likely
due to liver and serum monocyte-macrophage like cells
secreting cytokines into serum that are transported into
brain. In vivo, normal liver secretes little or no TNFα, how-
ever, in response to LPS liver Kupffer cells, resident
hepatic macrophages, secrete TNFβ and other cytokines
[23]. Kupffer cell removal from the liver blunts LPS-
induced proinflammatory cytokines (TNFα and IL-1β) in
serum, lung and kidney [24]. These data suggest that liver
Kupffer cells are responsible for a significant portion of
TNFα production in serum, which in turn could trigger
more TNFα in other tissues. Blood-born monocytes likely
contribute to serum levels as well. Transport across the
blood brain barrier has been reported for many cytokinesPage 11 of 17
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Ten daily doses of ethanol exposure reduced neurogenesis in hippocampal dentate gyrus during combined ethanol and LPS tr atmentsFigure 6
Ten daily doses of ethanol exposure reduced neurogenesis in hippocampal dentate gyrus during combined ethanol and LPS 
treatments. Male C57BL/6J mice were treated intragastrically with ethanol (5 g/kg, i.g.) for either 1 day or 10 days and injected 
intraperitoneally (i.p.) with LPS (3 mg/kg, i.p.) 24 hrs after ethanol treatment. Mice were sacrificed 1 hr following saline or LPS 
administration. Brain sections were fixed and stained with anti-mouse PCNA (a marker for proliferation of neural progenitor 
cells) and anti-goat doublecortin (a marker for immature or newly born neurons) antibodies. (A) Ethanol (5 g/kg, i.g., 1 day) 
pre-treated group, LPS did not show a decrease in the number of PCNA and doublecortin-IR cells. (B) Ethanol (5 g/kg, i.g., 10 
days) pre-treated mice, LPS significantly decreased PCNA and doublecortin-IR cells, suggesting that 10 daily doses of ethanol 
inhibits neurogenesis during combined ethanol and LPS treatments. (C) The pictures represent PCNA-IR cells in control 
(upper panel) and ETOH-LPS treated (lower panel) dentate gyri of the hippocampus. (D) Representative pictures of dou-
blecortin (DCX) immunoreactivity. DCX expression was shown in control brain (upper panel) and ETOH-LPS treated brain 
(lower panel).
Journal of Neuroinflammation 2008, 5:10 http://www.jneuroinflammation.com/content/5/1/10including TNF and IL-1, but not IL-10 [25]. Studies using
125I-TNFα in mice have found that TNFα is transported
into the brain within minutes after an intravenous injec-
tion [26], likely by TNF receptors used as transporters. Pre-
viously, we found that in TNF receptor 1 and 2 double
knock out mice (TNFR1/R2-KO) did not show significant
brain induction of proinflammatory cytokines (TNFα,
MCP-1) after injections of TNFα or LPS, whereas wild type
mice did show brain induction of proinflammatory
cytokines after peripheral injection of TNFα or LPS [2].
These findings are consistent with TNFα and other proin-
flammatory cytokines in serum carrying the proinflamma-
tory response from the serum into the brain. Thus, the
concordance of liver, serum and brain induced proinflam-
matory cytokine responses at 1 hour after LPS injection
with or without ethanol pretreatment is likely due to
cytokine synthesis from both liver Kupffer and blood
monocyte cells resulting in increasing serum levels that
are transported into brain inducing brain production of
proinflammatory cytokines.
Proinflammatory cytokine induction in liver and serum
subsides by one week. Surprisingly, IL-10, an anti-inflam-
matory cytokine, was induced by LPS at short time points
similar to proinflammatory cytokines; however, the IL-10
response persisted in liver whereas the proinflammatory
cytokines returned to control level. In human blood
monocytes IL-10 inhibits LPS and TNFα induction of IL-
1β and TNFα by blocking NF-κ B transcription [27,28]. In
liver, cytokines regulate immune response progression
from the early proinflammatory state that enhances anti-
gen presentation and Th1 lymphocyte infiltration to the
anti-inflammatory Th2 lymphocyte state [1]. Our studies
suggest that liver and systemic proinflammatory cytokines
are suppressed by IL-10, perhaps from regulatory lym-
phocytes, whereas the decreased IL-10 in the brain where
there are normally no lymphocytes, may contribute to the
prolonged increase in proinflammatory cytokines. It is
possible that ethanol induction of anti-inflammatory IL-
10 could have health benefit for diseases associated with
10 daily doses of inflammation and autoimmunity, how-
ever, additional studies need to be done to understand the
differential response of cytokines in the brain versus the
liver and serum.
Previous studies investigating the effects of ethanol in vivo
(i.g.) on serum LPS responses found that a single dose of
ethanol given before LPS can inhibit serum IL-6 and
serum acute phase response proteins indicative of inflam-
mation [29]. Similar to our study, a binge drinking dose
of ethanol alone increased serum acute phase proteins
with a peak response around 24 hrs. Low doses of ethanol
before LPS suppressed the LPS serum response. Our find-
ings that 10 daily binge doses of ethanol pretreatment
enhances the LPS-induced TNFα, MCP-1, IL-1β and
NADPH oxidase gp91phox subunit responses to LPS may
represent a type of supersensitivity. Ethanol is an antago-
nist when it is present that results in an increase in sensi-
tivity that lasts longer than the blood ethanol level.
Human monocytes isolated from the blood of alcoholics
are known to produce greater amounts of TNFα spontane-
ously and in response to endotoxin challenge [13]. Simi-
larly, liver Kupffer cell cultures isolated from chronic
ethanol pretreated rats have increased LPS-induced cal-
cium flux and increased production of TNFα [30] due in
part to ethanol up-regulation of the LPS receptor CD14
[31,32]. Thus, ethanol potentiation of short term liver and
serum induction of proinflammatory cytokines is likely
Table 3: Ten daily doses of ethanol and LPS induced changes in gene expression in brain and liver at 1 week
Gene Control ETOH LPS 0.03 LPS 0.3 LPS 3 LPS 0.03 + ETOH LPS 0.3 + ETOH LPS 3 + ETOH
Brain
TNFβ 100 ± 19 109 ± 17 113 ± 19 78 ± 21* 225 ± 21** 134 ± 6 172 ± 21* 307 ± 47**
MCP-1 100 ± 7 138 ± 5** 109 ± 8 122 ± 5* 163 ± 24* 139 ± 10* 150 ± 5**# 147 ± 13*
IL-1β 100 ± 8 114 ± 9 137 ± 10* 132 ± 19 132 ± 13 109 ± 9 108 ± 10 149 ± 23
gp91phox 100 ± 12 133 ± 4* 102 ± 14 151 ± 9* 156 ± 17* 166 ± 21*## 182 ± 18** 236 ± 30**#
p67phox 100 ± 6 133 ± 12* 113 ± 11 153 ± 6** 164 ± 15** 112 ± 10 136 ± 19 155 ± 22*
DBI 100 ± 16 199 ± 28* 187 ± 15** 181 ± 7** 217 ± 21** 219 ± 7** 239 ± 13**# 188 ± 43
IL-10 100 ± 28 ND ND ND ND ND ND ND
Liver
TNFβ 100 ± 11 116 ± 11 90 ± 9 110 ± 17 107 ± 16 110 ± 7 95 ± 10 115 ± 11
MCP-1 100 ± 6 110 ± 11 86 ± 16 100 ± 12 87 ± 14 102 ± 4 109 ± 9 104 ± 7
IL-1β 100 ± 21 93 ± 19 84 ± 18 63 ± 8 59 ± 6 40 ± 5* 39 ± 3* 43 ± 5*
IL-10 100 ± 21 243 ± 33* 222 ± 25*## 485 ± 92** 212 ± 49 427 ± 29** 312 ± 57* 281 ± 79
ND = not detected. Ten daily doses of ethanol and LPS induced changes in gene expression in brain and liver at 1 week. Male C57BL/6J mice were 
treated intragastrically with ethanol (5 g/kg, i.g.) daily for 10 days and injected intraperitoneally (i.p.) with LPS (3 mg/kg) 24 hrs after ethanol 
treatment. Brain and liver samples were collected 1 week post LPS treatment. Gene expression of proinflammatory and anti-inflammatory factors 
was measured by real-time PCR. The results are the means ± SEM (n = 6 per group). * P < 0.05, ** P < 0.01, compared with the saline controls. # P 
< 0.05, ## P < 0.01, compared with LPS-treated group.Page 13 of 17
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Effects of 10 daily doses of ethanol on IL-10 in brain and liver at 1 week after LPS treatmentFigure 7
Effects of 10 daily doses of ethanol on IL-10 in brain and liver at 1 week after LPS treatment. Male C57BL/6J mice were treated 
intragastrically with ethanol (5 g/kg, i.g.) for 10 days and were injected intraperitoneally (i.p.) with LPS at the indicated doses 24 
hrs after ethanol treatment. Brains and livers were collected at 1 week after LPS injection. The level of IL-10 protein was meas-
ured by ELISA. (A) Ten doses of ethanol decreased brain IL-10 and enhanced LPS-induced decrease in IL-10 in a LPS dose-
dependent manner at 1 week after LPS treatment. (B) There was a significant increase in liver IL-10 protein in 10 daily doses of 
ethanol, LPS (0.3 and 3 mg/kg) and ETOH-LPS groups. P < 0.05, ** P < 0.01, compared with the saline controls.# P < 0.05, ## P 
< 0.01, compared with the corresponding LPS-treated group.
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Ten daily doses of ethanol administration potentiated LPS-induced brain TNFα, MCP-1 and IL-1β production that remained el vated at 1 weekFigur  8
Ten daily doses of ethanol administration potentiated LPS-induced brain TNFα, MCP-1 and IL-1β production that remained 
elevated at 1 week. Male C57BL/6J mice were treated intragastrically with ethanol (5 g/kg, i.g.) for 10 days and were injected 
intraperitoneally (i.p.) with LPS at indicated doses 24 hrs after ethanol treatment. Brains were collected at 1 week after LPS 
injection. The levels of TNFα, MCP-1 and IL-1βprotein were measured by ELISA. (A) In the10-dose ethanol pre-treated group, 
brain TNFβ protein significantly increased in a LPS dose-dependent manner. (B) Exposure to 10 daily doses of ethanol resulted 
in a significant increase in brain MCP-1 in a LPS dose-dependent manner. (C) Brain IL-1βprotein synthesis was also enhanced by 
ethanol pre-treatment. The results are the means ± SEM (n = 6 per group). * P < 0.05, ** P < 0.01, compared with the saline 
controls.#P < 0.05, ## P < 0.01, compared with the corresponding LPS-treated group.
Journal of Neuroinflammation 2008, 5:10 http://www.jneuroinflammation.com/content/5/1/10due to increased liver Kupffer cell macrophage and blood
monocyte secretion of TNFα following chronic ethanol
pretreatment.
Ethanol pretreatment followed by LPS increased brain lev-
els of proinflammatory cytokines that persist for at least
one week. We previously found that a single dose of LPS
(5 mg/kg, i.p.) can induce brain TNFα for up to 10
months [2]. We report here that both LPS and ethanol
induce long lasting increases in several brain proinflam-
matory cytokines (LPS: TNFα, MCP-1, IL-1β and ethanol:
TNFα, MCP-1) and cause long lasting reductions in brain
anti-inflammatory cytokine IL-10. Ethanol not only sensi-
tizes proinflammatory cytokine production, but also
increases morphological signs of microglial response, e.g.
increased cell size, irregular shape and intensified Iba1
staining. Neurogenesis represents a growth and regenera-
tive component of adult brain which when inhibited rep-
resents a form of degeneration. In this study, we found
that neurogenesis was significantly decreased in 10 daily
doses of ethanol-LPS treated animals. Both proliferation
of hippocampal neuroprogenitors and newly born neu-
ron differentiation were significantly decreased in 10 daily
doses of ethanol-LPS treated animals. Multiple doses of
LPS reduce neurogenesis that is reversed by indomethicin,
a common anti-inflammatory drug [6], suggesting that
inflammation can inhibit neurogenesis. It is possible that
ethanol enhancement of LPS induced proinflammatory
cytokines results in greater inflammation that contributes
to the inhibition of neurogenesis. Neurodegeneration is
associated with inflammation and oxidative stress
[33,34]. Whether inflammation may cause oxidative
stress in systemic LPS and alcohol treated animals is
unknown. Here we report that 10 daily doses of ethanol
significantly up-regulates NADPH oxidase (the main
ROS-producing enzyme during inflammation) subunits,
gp91phox and p67phox, and potentiates LPS-induced induc-
tion of these two subunits that persists for at least 1 week
(Table 1 and 3). These changes coincide with microglial
activation and production of proinflammatory cytokines
observed in either LPS or ETOH-LPS treated groups. LPS
and ethanol induced persistent proinflammatory cytokine
induction could impact neurodegenerative diseases long
after systemic infection and alcohol induced systemic
proinflammatory cytokines.
Disruption of cytokine cascades has been implicated in a
variety of diseases including cardiovascular, liver, respira-
tory, inflammatory, metabolic, and brain diseases as well
as certain cancers. Our findings of altered systemic
cytokine levels following ethanol may have broad effects
on health. In humans chronic alcohol consumption is
associated with increases in serum proinflammatory
cytokines [11,12] and monocytes isolated from the blood
of alcoholics produce greater amounts of TNFα spontane-
ously and in response to endotoxin [13]. Similarly,
chronic alcohol drinking in female rats results in
increased levels of ovarian, pituitary and hypothalamic
TNFα and IL-6 [35], likely due to systemic proinflamma-
tory cytokine activation. It is possible that the alcohol
induced increased risk for cardiovascular, liver, respira-
tory, infectious, mental and neurological diseases as well
as certain cancers [7] is related to alcohol disruption of
cytokine cascades. Our discovery that ethanol increases
systemic induction of TNFα, MCP-1 and IL-1β, and
increases NADPH oxidase could contribute to pathologies
in multiple tissues and organ systems. Our finding that
the systemic potentiation initiates a long lasting self-pro-
pelling brain proinflammatory cytokine cascade includ-
ing up-regulation of NADPH oxidase could contribute to
the multiple CNS pathologies including alcoholic demen-
tia. Additional studies will be needed to understand the
role of systemic proinflammatory cytokines in chronic
diseases and how prolonged increases in proinflamma-
tory cytokines in brain contribute to neurodegeneration
and other CNS pathologies.
Conclusion
In summary, we report that LPS increases liver, serum and
brain proinflammatory cytokines. One dose of ethanol
induced TNFα, MCP-1 and COX-2 proinflammatory
mRNA in brain, but not liver. Pretreatment with a single
dose of ethanol potentiated LPS induction of proinflam-
matory mRNA in brain for NADPH oxidase gp91phox sub-
unit as well as increasing both IL-1β mRNA and protein in
brain. Treatment with ethanol for 10 days increased
proinflammatory cytokines, TNFα, MCP-1 mRNA and
protein in brain as well as mRNA for NADPH oxidase
gp91phoxsubunit. Pretreatment for 10 days with ethanol
potentiated LPS-induced proinflammatory cytokines in
liver, serum and brain, as well as the production of anti-
inflammatory cytokine, IL-10, in liver, but not in brain.
Brain proinflammatory cytokines and enzymes remain
elevated after liver and serum proinflammatory cytokines
have returned to control levels. Prolonged increases in
proinflammatory cytokines may contribute to a variety of
systemic and central nervous system pathologies.
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